Profil
Kevin V.
Sullivan is a professional with experience in the biotech industry.
He is currently a Director at Qing Bile Therapeutics, Inc. His former positions include Chief Executive Officer at DeNovaMed, Inc., Chief Executive Officer & Director at Appili Therapeutics, Inc., and Chief Operating Officer at Viron Therapeutics, Inc. Sullivan holds an MBA from the Richard Ivey School of Business.
Postes actifs de Kevin V. Sullivan
| Sociétés | Poste | Début |
|---|---|---|
Qing Bile Therapeutics, Inc. | Directeur/Membre du Conseil | 01/05/2015 |
Anciens postes connus de Kevin V. Sullivan
| Sociétés | Poste | Fin |
|---|---|---|
| APPILI THERAPEUTICS INC. | Directeur Général | 02/12/2019 |
DeNovaMed, Inc.
DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology Develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs | Directeur Général | 01/04/2015 |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Directeur des opérations | 01/05/2013 |
Formation de Kevin V. Sullivan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Health Technology |
DeNovaMed, Inc.
DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology Develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs | Health Technology |
Richard Ivey School of Business
Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Appili Therapeutics, Inc.
Appili Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for infectious disease | Health Technology |
Qing Bile Therapeutics, Inc. |
















